Clinical trial
Apomorphine in Parkinson's Disease Patients With Visual Hallucinations
NCT02702076 · University Medical Center Groningen, Other · Unknown status
Key facts
| NCT number | NCT02702076 |
|---|---|
| Title | Apomorphine in Parkinson's Disease Patients With Visual Hallucinations |
| Official title | Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy of Continuous Subcutaneous Infusion in Parkinson's Disease Patients With Refractory Visual Hallucinations |
| Lead sponsor | University Medical Center Groningen, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Parkinson's Disease, Hallucinations, Visual |
| Intervention type | Drug |
| Interventions | Apomorphine, Placebo |
| Enrollment | 35 |
| Start date | May 1, 2017 |
| Primary completion | Dec 1, 2017 |
| Completion | Dec 1, 2017 |
| First posted | Mar 8, 2016 |
| Last update posted | May 3, 2017 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: